The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization.

CR Maliszewski, GJ Delespesse… - … (Baltimore, Md.: 1950 …, 1994 - journals.aai.org
CR Maliszewski, GJ Delespesse, MA Schoenborn, RJ Armitage, WC Fanslow, T Nakajima…
Journal of immunology (Baltimore, Md.: 1950), 1994journals.aai.org
Abstract CD39, a 70-to 100-kDa molecule expressed primarily on activated lymphoid cells,
was previously shown to mediate B cell homotypic adhesion when ligated with a subset of
anti-CD39 mAbs. In the present study, we describe the cloning and molecular
characterization of human and murine CD39. The nucleotide sequence of human CD39
includes an open reading frame encoding a putative 510 amino acid protein with six
potential N-linked glycosylation sites, 11 Cys residues, and two potential transmembrane …
Abstract
CD39, a 70- to 100-kDa molecule expressed primarily on activated lymphoid cells, was previously shown to mediate B cell homotypic adhesion when ligated with a subset of anti-CD39 mAbs. In the present study, we describe the cloning and molecular characterization of human and murine CD39. The nucleotide sequence of human CD39 includes an open reading frame encoding a putative 510 amino acid protein with six potential N-linked glycosylation sites, 11 Cys residues, and two potential transmembrane regions. Murine CD39 shares 75% amino acid sequence identity with human CD39 but fails to cross-react with anti-human CD39 mAbs. Although there were no significant similarities with other mammalian genes, considerable homology was found between CD39 and a guanosine diphosphatase from yeast. A series of mouse-human hybrid molecules was constructed to determine the general topology of CD39 and the location of a biologically functional epitope. These findings and supporting evidence from an anti-CD39 mAb-selected phage peptide display library indicate a likely model wherein a short intracellular N-terminus is followed by a large extracellular loop containing the epitope recognized by stimulatory anti-CD39 mAbs, and a short intracellular C terminus. The results demonstrate that CD39 is a novel cell surface glycoprotein with unusual structural characteristics.
journals.aai.org